1 citations
,
December 2023 in “Value in Health” This study assessed the effectiveness of the EQ-5D in measuring health-related quality of life for alopecia areata patients and found it may not accurately capture the burden of the condition, particularly its psychosocial impact, compared to other more condition-specific measures.
3 citations
,
November 2023 in “BMC Public Health” In this study, EQ-5D-5L and SF-6DV2 showed suitable measurement properties in assessing health utility among Chinese university staff and students, though they reported differences in sensitivity and cannot be used interchangeably.
1 citations
,
July 2024 in “PharmacoEconomics - Open” This study indicates that the EQ-5D-5L may not effectively capture the burden of alopecia areata on patients' health-related quality of life, and suggests that alternative measures might better assess treatment benefits related to hair regrowth.
June 2026 in “Value in Health” 3 citations
,
May 2015 in “Journal of The American Academy of Dermatology” Adalimumab significantly improves quality of life for patients with moderate to severe hidradenitis suppurativa.